Blaine Davis - 28 Nov 2022 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
Chief Financial Officer
Signature
Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
Issuer symbol
RNAC
Transactions as of
28 Nov 2022
Net transactions value
$0
Form type
4
Filing time
30 Nov 2022, 15:40:25 UTC
Previous filing
19 Jul 2022
Next filing
15 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Employee Stock Option (right to buy) Award $0 +1,250,000 $0.000000 1,250,000 28 Nov 2022 Common Stock 1,250,000 $1.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% on November 28, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.